Dr. Clemens is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3471 5th Ave
Ste 810
Pittsburgh, PA 15213Phone+1 412-692-4920
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Neurology, 1988 - 1990
- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Neurology, 1985 - 1988
- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalInternship, Internal Medicine, 1984 - 1985
- MCP-Hahnemann College of MedicineClass of 1984
Certifications & Licensure
- PA State Medical License 1995 - 2024
- TX State Medical License 1993 - 1995
- MN State Medical License 1988 - 1993
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011
Clinical Trials
- Longitudinal Study of the Natural History of Duchenne Muscular Dystrophy (DMD) Start of enrollment: 2005 Dec 01
- Cardiac Magnetic Resonance in Children With Muscular Dystrophy Start of enrollment: 2010 Apr 01
- Clinical Trial of Coenzyme Q10 and Lisinopril in Muscular Dystrophies Start of enrollment: 2010 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- Safety and efficacy of viltolarsen in ambulatory and nonambulatory males with Duchenne muscular dystrophy.Amy D Harper, Haluk Topaloglu, Eugenio Mercuri, Vasiliy Suslov, Liwen Wu
Scientific Reports. 2024-10-08 - 39 citationsSafety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, d...Benedikt Schoser, Mark Roberts, Barry J. Byrne, Sheela Sitaraman, Hai Jiang
The Lancet. Neurology. 2021-12-01 - 5 citationsRasch Analysis of the Pediatric Quality of Life Inventory 4.0 Generic Core Scales Administered to Patients With Duchenne Muscular DystrophyErik Landfeldt, Joel Iff, E. Henricson, V. Vishwanathan, S. Chidambaranathan
Value in Health. 2021-10-01
Journal Articles
- Safety, Tolerability, and Efficacy of Viltolarsen in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 SkippingPaula R Clemens, Vamshi K Rao, Craig M Zaidman, JAMA Neurology
Authored Content
- Safety, Tolerability, and Efficacy of Viltolarsen in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 SkippingMay 2020
Press Mentions
- ReveraGen and Santhera Announce FDA Orphan Grant Funding for Clinical Trial with Vamorolone in Becker Muscular DystrophySeptember 27th, 2021
- Long-Term Viltepso Prevents Motor Function Decline in DMD BoysJuly 13th, 2021
- VILTEPSO® (Viltolarsen) Injection: Long-Term Efficacy and Safety Data Presented at the PPMD 2021 Virtual Annual ConferenceJuly 1st, 2021
- Join now to see all
Grant Support
- Network Of Excellence In Neuroscience Clinical Trials (Univ Of Pittsburgh Crs)National Institute Of Neurological Disorders And Stroke2011
- Becker Muscular Dystrophy: A Natural History Study To Predict Efficacy Of EXON SKNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2011
- Genetic Rescue Of Dystrophic Muscle In UteroNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2004–2008
- Genetic Rescue Of Dystrophic Mucle In UteroNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2005–2006
- Core--Training ProgramNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2003
- Analysis And Modulation Of Immunity In Gene TherapyNational Institute Of Allergy And Infectious Diseases1999–2003
- Longterm Rescue Of Muscle Function By Dystrophin Delivery--Adenoviral VectorsNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999–2002
- Core--Mouse BreedingNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1999–2002
- Gene Therapy For Duchenne Muscular DystrophyNational Institute Of Neurological Disorders And Stroke1996–2000
- Gene Therapy For Duchenne Muscular DystrophyNational Institute Of Neurological Disorders And Stroke1993–1995
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: